D. E. Shaw & Co., Inc. Novavax Inc Put Options Transaction History

D. E. Shaw & Co., Inc.

  • $107 Billion
  • Q3 2024

Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$4.8 - $7.67 $252,000 - $402,675
-52,500 Reduced 46.67%
60,000 $288,000
Q3 2023

Nov 14, 2023
BUY
$6.81 - $9.74 $340,500 - $487,000
50,000 Added 80.0%
112,500 $814,000
Q4 2022

Feb 14, 2023
SELL
$8.86 - $25.04 $177,200 - $500,800
-20,000 Reduced 24.24%
62,500 $642,000
Q3 2022

Nov 14, 2022
SELL
$18.2 - $76.12 $536,900 - $2.25 Million
-29,500 Reduced 26.34%
82,500 $1.5 Million
Q2 2022

Aug 15, 2022
SELL
$36.28 - $75.29 $9.11 Million - $18.9 Million
-251,100 Reduced 69.15%
112,000 $5.76 Million
Q1 2022

May 16, 2022
BUY
$69.73 - $142.9 $9.74 Million - $20 Million
139,700 Added 62.53%
363,100 $26.7 Million
Q4 2021

Feb 14, 2022
SELL
$134.56 - $217.97 $2.69 Million - $4.36 Million
-20,000 Reduced 8.22%
223,400 $32 Million
Q3 2021

Nov 15, 2021
SELL
$177.8 - $270.58 $8.73 Million - $13.3 Million
-49,100 Reduced 16.79%
243,400 $50.5 Million
Q2 2021

Aug 16, 2021
BUY
$121.0 - $257.67 $28.6 Million - $61 Million
236,700 Added 424.19%
292,500 $62.1 Million
Q1 2021

May 17, 2021
SELL
$112.98 - $319.93 $5.12 Million - $14.5 Million
-45,300 Reduced 44.81%
55,800 $10.1 Million
Q3 2020

Nov 16, 2020
BUY
$79.44 - $178.51 $8.03 Million - $18 Million
101,100 New
101,100 $11 Million

Others Institutions Holding NVAX

# of Institutions
292
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $630M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email